^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    U87

    i
    Other names: U87, U87 CAR-T, U 87, U-87
    Associations

    News

    Trials
    Company:
    Shanghai Unicar
    Drug class:
    TROP-2-targeted CAR-T immunotherapy
    Associations

    News

    Trials
    1year
    U87 CAR-T in Patients With Advanced Head and Neck Tumors (clinicaltrials.gov)
    P1, N=20, Recruiting, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
    New P1 trial • Metastases
    |
    U87
    2years
    U87 CART in Treatment of Advanced Pancreatic Cancer (clinicaltrials.gov)
    P1, N=12, Recruiting, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Trial primary completion date: Oct 2023 --> Dec 2024
    Trial primary completion date • Metastases
    |
    cyclophosphamide • U87
    3years
    U87 CART in Treatment of Advanced Pancreatic Cancer (clinicaltrials.gov)
    P1, N=12, Recruiting, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
    New P1 trial • Metastases
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2)
    |
    cyclophosphamide • U87